Evidence map›Paper›PMID 29996332›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2018

[An evidence-based terlipressin therapy for gastroesophageal variceal hemorrhage].

X M Zhou, X S Qi, J D Jia

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03846180 (Terlipressin Versus Somatostatin/Octreotide on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03846180 completednot on this mapstarted 2019, after this paper: background citation

Terlipressin Versus Somatostatin/Octreotide on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage (TORCH): A Retrospective Multicenter Observational Study

TypeobservationalSponsorGeneral Hospital of Shenyang Military RegionRan2019 to 2019Enrolled1,682ConditionsVariceal Hemorrhage, Cirrhosis, Liver, Kidney InjuryArmsTerlipressin, Somatostatin, Octreotide
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. [Research progress of terlipressin in the treatment of cirrhotic ascites-related complications].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2019
    Review
  2. [Observation of the therapeutic and characteristic effects of terlipressin on refractory cirrhotic ascites].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2019
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

X M ZhouGraduate School, Jinzhou Medical University, Jinzhou 121000, China.
X S QiDepartment of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang 110840, China.
J D JiaCenter for Liver Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastroesophageal variceal bleeding is one of the major complications of cirrhosis and also the leading causes of death in patients with decompensated cirrhosis. Terlipressin is a triglycyl-lysine vasopressin, a synthetic vasopressin analogue that is mainly used for the treatment of acute variceal hemorrhage. This article aims to review the current status of treatment of gastroesophageal variceal bleeding with terlipressin from the perspective of evidence-based medicine.

Indexed as

Esophageal and Gastric VaricesGastrointestinal HemorrhageHumansLiver CirrhosisTerlipressinTreatment OutcomeVaricose VeinsVasoconstrictor AgentsTerlipressinVasoconstrictor AgentsClinical trialLiver cirrhosisVaricose veins

Identifiers

PMID29996332
PMCPMC12770667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.